Clinical, Anatomic, and Electrophysiologic Evaluation Following Intravitreal Bevacizumab for Macular Edema in Retinal Vein Occlusion
- 30 April 2007
- journal article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 143 (4), 601-606.e2
- https://doi.org/10.1016/j.ajo.2006.12.037
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- ELECTROPHYSIOLOGIC FINDINGS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTRetina, 2006
- Bevacizumab in the treatment of colorectal cancerExpert Opinion on Biological Therapy, 2005
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Week Results of an Uncontrolled Open-Label Clinical StudyOphthalmology, 2005
- Targeting angiogenesis, the underlying disorder in neovascular age-related macular degenerationCanadian Journal of Ophthalmology, 2005
- Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patientsAlbrecht von Graefes Archiv für Ophthalmologie, 2004
- Standard for clinical electroretinography (2004 update)Documenta Ophthalmologica, 2004
- Visual evoked potentials standard (2004)Documenta Ophthalmologica, 2004
- Guidelines for basic multifocal electroretinography (mfERG)Documenta Ophthalmologica, 2003
- Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein OcclusionAmerican Journal of Ophthalmology, 2002
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersThe New England Journal of Medicine, 1994